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Accurate determination of selenium (Se) species in biological samples is a critical issue because Se
commonly occurs at low levels and in diverse species. The method for the full quantification of Se
species in serum samples was proposed through combined ion-pair reverse-phase (RP)
chromatography and affinity chromatography (AF) hyphenated to inductively coupled plasma-
(quadrupole) mass spectrometry (ICP-qMS) with post-column isotope dilution analysis (IDA) and
a collision cell technique (CCT). Different Se species like inorganic Se (Se4+ and Se6+), selenocystine
(SeCys), selenomethionine (SeMet), selenoprotein P (SelP), selenoalbumin (SeAlb) and glutathione
peroxidase (GPx) can be separated and quantified. The proposed methodology was used to
qualitatively and quantitatively study the dynamic distribution of Se species in human serum samples
from the Hg-contaminated area after supplementation with 100 mg of Se daily as Se-enriched yeast for
180 days. SelP takes up almost half and even more of the total Se and increases with the Se
administration. The repeatability in terms of relative standard deviation (R.S.D. %, n ¼ 10) is 6% for
GPx and SelP and 5% for SeAlb. The detection limits are 0.1 mg Se L1 for GPx and other non-retained
Se compounds, 1.0 mg Se L1 for SelP and 1.2 mg Se L1 for SeAlb, 1.3 mg Se L1 for inorganic Se; 1.2 mg
Se L1 for SeCys; 1.1 mg Se L1 for SeMet, respectively.
Introduction
Selenium (Se) is an essential micronutrient because of its unique
antioxidant properties and its ability to regulate thyroid gland
metabolism.1
As a well-known highly hazardous element, mercury (Hg) can
bring toxic effects to the immune system, kidneys, lungs, and
nervous tissues, and is linked with a number of human health
diseases.2 The town of Wanshan in Guizhou was once the major
Hg-mining area in China, where large-scale production of Hg
lasted for more than 50 years before closure in 2002. Owing to the
natural and anthropogenic factors, people living in this area
suffered elevated Hg exposure and increased oxidative damage.3–5
A Se supplementation trial in persons exposed to Hg through
fish consumption (in which most Hg is in an organic form as
methylmercury) found reduced pubic hair Hg level,6 which sug-
gested the reduced accumulation of Hg after Se supplementation.
However, to the best of our knowledge, there is no investigation
on the effects of Se supplementation in long-term Hg-exposed
populations living in Hg-mining area, who are exposed mostly to
inorganic and elemental Hg. Therefore, a study was initiated to
evaluate the effects of Se supplementation in Hg-exposed
volunteers from Wanshan Hg-mining area. Hair, urine and
blood samples were collected. Increased excretion of Hg was
found after Se supplementation and the major Hg and Se species
were characterized in the urine samples.7 However, no correla-
tion between Hg and Se was found in these urine samples
although the coaccumulation of Se and Hg in human and other
mammalian organisms had been long found.8 As the extension of
this work, the coaccumulation of Se and Hg in human serum
samples will be further studied. In this study, however, only the
Se species in serum samples before and after Se supplementation
in these volunteers will be studied.
Se is mainly incorporated into three proteins in serum, i.e.
glutathione peroxidase (GPx), selenoprotein P (SelP) and
albumin (SeAlb), which can be separated by anion exchange
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chromatography (AEC),9,10 size exclusion chromatography
(SEC)11 or affinity chromatography (AC).9,12,13 However, quan-
titative study could only find about 90.7%10 and 85.9–92.5%9 of
total Se in serum. About 10% of total Se in serum is still
unidentified.
Information on the presence of selenoamionacids and inor-
ganic Se in serum is scarce. Previous work has established and
optimized analytical methods to identify and quantify selenoa-
minoacids and inorganic Se in biological samples by reverse-
phase chromatography (RP).7,14–16 To our knowledge, there were
few articles to qualitatively and quantitatively determine both
small molecular selenocompounds and Se-containing proteins in
human serum samples. Therefore, in this study we proposed
a method by the combination of RP and AF chromatography
coupled to ICP-MS. Through the proposed method, Se-con-
taining proteins (SelP, SeAlb, GPx), and small selenocompounds
like SeCys, SeMet, inorganic Se in serum in Hg-exposed people
after Se supplementation can be separated and quantified by RP
and AF-ICP-qMS with post-column isotope dilution analysis
(IDA) and a collision cell technique (CCT). The dynamic
distribution of Se species in human serum samples will also be
studied.
Experimental
Instrument
A Symmertryshield RP18 column (150  3.9 mm, Waters, Mil-
ford, USA) and affinity ‘‘HiTrap-heparin’’ sepharose (1 mL) and
‘‘HiTrap-blue’’ sepharose (1 mL) columns (Pharmacia, Uppsala,
Sweden) were employed for the separation of the small molecular
Se compounds and selenocontaining proteins. The columns were
connected to a HPLC system consisting of a liquid chromatog-
raphy pump (WAT055028 metal-free 626 pump, Waters, Mil-
ford, USA). A six-way Rheodyne valve (Model 5012) was also
used for affinity chromatography. The continuous addition of
the spike was performed by a peristaltic pump (Model HP4,
Scharlau Science, Barcelona, Spain). Samples were loaded with
a syringe into a 100 mL sample loop. All separations were per-
formed at room temperature. UV measurements were performed
with a Waters 484 UV/VIS absorption detector (Waters
Corporation, MA, USA). All solutions were prepared with Milli-
Q water (18.2 MU cm), and filtrated with a 0.22 mm microporous
membrane. The column was connected directly to the nebulizer
of the ICP-MS system with polyether ether ketone (PEEK)
tubing (0.13 mm i.d.). The signal of ICP-MS was triggered by the
manual injector of the HPLC. A Thermo Elemental X7 ICP-MS
(Thermo Electron Co., USA) was used as the element detector.
Optimization was carried out daily with a normal tuning solution
(1 ng mL1, Be, Co, In, U). Raw data were collected by the
PlasmaLab software through a personal computer. The peak
areas of elemental signals of ICP-MS were used for quantitative
analysis online. A continuous flow of 7.5 mL min1 of hydrogen
and helium was introduced into the collision cell as reaction gas.
The sample introduction system consisted of a classical Mein-
hard nebuliser with a Scott double-pass quartz spray chamber
cooled down to 2 C. The collision cell technique (CCT) was
employed for the elimination of the polyatomic interferences of
40Ar40Ar and others in the detection of 80Se. The ICP-MS and the
HPLC operating conditions used in this work are summarized in
Table 1.
Reagents and standards
All reagents were of analytical reagent grade. Hepta-
fluorobutanoic acid (HFBA) was purchased from Fluka (Swit-
zerland), while Triton X-100 from Amersco (USA). Ammonium
acetate and nitric acid were obtained from Beihua (China), while
methanol from Guangfu (China). Enriched 78Se was obtained
from Cambridge Isotope Laboratories (USA).
Stock standard solutions of 100 mg Se L1 were prepared in
deionized water from selenocysteine (Sigma, St. Louis, USA),
selenomethionine (Sigma, St. Louis, USA), sodium selenate
(Na2SeO4, Alfa Aesar), sodium selenite (Na2SeO3, Zhonglian,
China). The working standard solutions were prepared in Milli-
Q water by dilution of stock solutions as required daily and
stored in the dark.
Collection and preparation of serum samples
Whole blood samples were collected from 53 volunteers from
Wanshan Hg-mining area who had been supplemented with 100
mg of Se per day from day 0 to 180 in the form of Se-enriched
yeast (SelenoPrecise, Pharma Nord, Denmark). The blood
samples were collected on day 0 to day 30, 60, 90, 120, 150, 180
and 360, where day 0 was the day before the supplementation
Table 1 The instrumental Parameters of ICP-MS and HPLC
Plasma parameters
Power 1350 W
Plasma Ar flow rate 13 L min1
Carrier Ar flow rate 0.75 L min1
Nebulization Ar rate 0.84 L min1
CCT gas and the flow rate 92.72% (He) + 7.29% (H2),7.5 mL
min1
Isotopes monitored Se: 76, 77, 78, 80, 82
Dwell time for each isotope 10 ms
Acquisition mode Time resolved analysis
Reverse-phase ion-pair HPLC Conditions
Column Symmertryshield RP18, 150  3.9
mm
Mobile phase A 0.3% CH3OH + 0.1% HFBA
Mobile phase B 5% CH3OH + 0.1% HFBA
Gradient program 0–4 min, mobile phase A, 4–12 min,
mobile phase B
Flow rate 1.0 mL min1
Injection volume 0.1 mL
Pressure 1700 Psi
Affinity column HPLC Conditions
Columns Hitrap heparin-sepharose (1 mL),
Hitrap blue-sepharose (1 mL)
Injection volume 0.1 mL
Flow rate 0.8 L min1
Pressure 250 Psi
Mobile phase A Binding buffer, ammonium acetate,
0.05 mol mL1, pH 7
Mobile phase B Elution buffer, ammonium acetate,
1.5 mol mL1, pH 7
Gradient program 0–5 min, position 1 (P1), mobile
phase A; 5–10 min, position 2
(P2), mobile phase B; 10–15 min,
position 1(P1), mobile phase B;
15–20 min, position 1(P1),
mobile phase A
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and day 30 to 60, 90, 120, 150, 180, and 360 were the corre-
sponding days after supplementation. The blood samples of at
least 5 mL were collected in the morning after overnight fasting.
The serum samples were obtained by centrifugation (10 min at
1500 g) 2–4 h after blood collection and stored at 20 C until
analysis. Serum samples were analyzed within a week after the
collection.
Serum samples were simply 1 : 4 diluted with 0.05 mol L1
ammonium acetate (pH ¼ 7) and centrifuged at 10000 g for 30
min by centrifugal filtration tube (molecular weight cut off at
3000 Da). Supernatant (molecular weight > 3000 Da) is prepared
for quantitative analysis of GPx, SelP and SeAlb, while lower-
layer liquid (molecular weight < 3000 Da) is used for quantitative
analysis of Se4+ and Se6+ (inorganic Se), SeCys, and SeMet. Prior
to injection, all samples were filtrated with 0.45 mm microporous
membrane.
Analytical procedures
Total Se concentration analysis. To measure the total amount
of Se, serum samples diluted by 1 : 4 with solution (0.1% HNO3
+ 0.1% HFBA + 0.1% Triton X-100) were directly introduced
into ICP-qMS by 2% (v/v) HNO3. The recovery was 97% by
using human serum reference materials BCR-637 from our
experiments. The ICP-MS condition, which was the same as Se
speciation, shown in Table 1.
Ion-pair reverse-phase chromatography. Using reverse-phase
ion-pair chromatography for separation of Se compounds can be
found in a large number of papers.15–19 We also adopted this
method to study the Se species in urine and other biological
samples.7,14 Here, the ICP-MS and chromatographic conditions
were optimized for the separation of Se species in human serum
(inorganic Se, SeCys, and SeMet). Calibration curves were used
for quantification of these Se species and mixed standards of Se4+
and Se6+, SeCys, SeMet at 1, 5, 10, 50, 100 mg Se L1 were diluted
as required daily.
Affinity chromatography. The fractionation of Se-containing
proteins in human serum was achieved by affinity chromatog-
raphy.9,12 The operating and chromatographic conditions are
shown in Table 1 and the whole experimental arrangement is
shown in Fig. 1.
In Fig. 1, the heparin-sepharose column 1 can selectively retain
SelP, while the blue sepharose 2 can retain both SelP and
albumin. The serum samples first passed through both column 1
and 2 using mobile phase A, where SelP was retained in column 1
and SeAlb in column 2 at position 1 (P1). GPx and other non-
retained Se compounds were first eluted since they lack affinity
for heparin or blue-sepharose. Then mobile phase B was used to
elute SelP at position 2 (P2). The SeAlb was eluted using mobile
phase B at P1, then mobile phase A was used at P1 for the
preparation of the next injection. The outlet of the chromato-
graphic column was connected through a T-piece where an
enriched 78Se spike was continuously added with a flow rate of
0.8 mL min1 and the mixture was nebulized into the plasma for
the measurement of the Se in binding proteins in human serum.
Species-unspecific isotope dilution analysis. As is known, one of
the most important advantages of the use of the species-unspe-
cific spiking is the possibility to determine the level of certain
element in a compound without knowing the structure and
composition.9,20 After correcting for dead time, spectral inter-
ference and mass bias, the isotope ratio chromatogram was
converted into the mass flow chart by the isotope ratio equation
calculation. The absolute elemental amount in the different
protein fractions could be calculated by the integration of the
corresponding peaks in the mass flow chart.9
Fig. 1 Scheme of Se species analysis in human serum including small Se compounds and Se-containing proteins by ion-pair reverse-phase chroma-
tography and affinity chromatography coupled to post-column isotope dilution analysis ICP-MS, where in the AF columns, column 1 is heparin
sepharose, column 2 is blue-sepharose.
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Results and discussion
Separation and quantification of small molecular
selenocompounds
As is known to all, the pH value and methanol concentration in
the mobile phase and the concentrations of ion-pair reagents can
affect the separation efficiency of small molecular seleno-
compounds. Here, chromatographic parameters, such as the
concentrations of HFBA and methanol was further changed and
optimized. When mobile phase contained 2% CH3OH and 0.1%
HFBA, peaks obtained from aqueous SeMet standard was
broader and the elution time was longer than that using the
mobile phase containing 5% CH3OH and 0.3% HFBA. Conse-
quently, the later was also used to reduce the elution time of
SeMet.
The chromatogram of the small molecular Se compounds is
shown in Fig. 2. It is hard to separate Se4+ and Se6+. However, the
separation of Se4+ and Se6+ in serum samples can be achieved by
using anion exchange column that was reported in our other
paper.21 We found that Se4+ is the major inorganic Se forms but
only accounts for 1.8% to 2.6% of total Se.
Calibration curves based on peak area were linear with
correlation coefficients (r2), which is better than 0.9992 for each
species in the range studied (1–100 ng mL1). The detection limits
were estimated based on the concentration (as element) necessary
to yield a net signal equal to three times the standard deviation of
the background. The IP-RP-HPLC method detection limits (as
element) were 1.3, 1.2, and 1.1 ng mL1 for Se4+ and Se6+, SeCys,
SeMet, respectively.
Quantification of SelP, SeAlb, GPx and other non-retained Se
compounds by AF-IDA-ICP-qMS
Fig. 3 shows the separation and isotope dilution analysis of Se-
containing proteins in serum. It is well known for isotope ratio
accurate measurements, every intensity value in the chromato-
gram had to be corrected for the dead time, which was 35 ns
using the usual correction equation.9,22,23 After dead time and
mass bias correction, the corrected final mass flow chromato-
grams in Fig. 3(b) were evaluated from the ratios of 80Se/78Se in
Fig. 3(a) using the online isotope equation.20 The intensity of
a protein was monitored by UV at 254 nm online as shown in
Fig. 3(c). The application of ion-guiding multipole collision cells
in ICP-MS using helium as a buffer and hydrogen as a reaction
gas is an effective means of reducing or even suppressing argon
induced polyatomic ion interferences, 40Ar40Ar and 38Ar40Ar, on
the main Se isotopes 80Se and 78Se, respectively.
The use of affinity chromatography by a heparin-sepharose
column coupled to a reactive blue-sepharose column allows for
a rapid, precise and convenient fractionation of the three main
Se-containing proteins in human serum (GPx, SelP and SeAlb).
The repeatability in terms of relative standard deviation (R.S.D.
%, n ¼ 10) is 6% for GPx and SelP and 5% for SeAlb. The
detection limits are also calculated according to the 3s criterion.
LODs are 0.1 mg Se L1 for GPx and other non-retained Se
compounds, 1.0 mg Se L1 for SelP and 1.2 mg Se L1 for SeAlb,
respectively.
Full quantification of both small molecular selenocompounds and
selenoproteins in serum samples from one subject
The quantitative results of inorganic Se, SeCys, SeMet, GPx,
SelP and SeAlb in serum samples from one subject before and
after Se supplementation through the combined application of
Fig. 2 Chromatogram of the small molecular Se compounds in a serum
sample. Column: Symmertryshield RP18, 150  3.9 mm, mobile phase:
A, 0.3% CH3OH + 0.1% HFBA, B, 5% CH3OH + 0.3% HFBA, 0–4 min,
A, 4–12 min, B, flow rate: 1 mL min1, injection volume: 0.1 mL.
Fig. 3 (a), Corresponding Se isotope ratio chromatograms for 80Se/78Se
after mathematical corrections. (b), Mass flow chromatogram obtained
for 80Se/78Se isotope ratios in a serum sample by AF-HPLC. (c), Corre-
sponding UV signal (l ¼ 254) of GPx and non-retained Se compounds,
SelP, SeAlb in a serum sample.
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RP and AF columns hyphenated to ICP-MS are shown in Fig. 4.
The undetected Se species was calculated as the total Se contents
minus all the detected Se species.
It was found that the total Se significantly increased after Se
supplementation by day 0 to day 180, whereas it dropped after
the cease of Se supplementation on day 360. It should be noted
that the Se level in serum after Se supplementation (d360) are still
higher than that before Se supplementation (d0) even after 6
months, which suggest organic Se (Se-enriched yeast in our case)
supplementation is efficient to increase serum Se concentrations
and this is in agreement with other studies.24
The distribution of Se in different Se species in serum samples
from one subject on different days is shown in Table 2. On day 0,
Se in SelP, SeAlb and GPx accounts for 61%, 8.1%, 8.7% of total
Se, where the distribution of SelP and SeAlb are almost the same
as other study but the GPx is less than other study.9 In the study
by Reyes et al., the GPx peak stands also for the non-retained Se
compounds, which may be the small molecular Se compounds in
our study. Therefore, if the small molecular Se compounds are
considered, which accounts for 15.7% of total Se, our results also
agree well with their finding.9
On day 0, trace amount of Se in inorganic Se, SeCys and
SeMet in serum sample were found, which accounts for 4.4%,
7.1% and 4.2% of total Se, respectively. Using SEC, Palacios
et al.11 did not find such Se molecules, however, this may be
attributed to the poor resolving power of SEC. In our study, the
undetected Se on d0 through our method accounts for 6.5% of
total Se, which suggests other Se species exist.
After Se supplementation, the distribution of Se in SelP and
SeAlb increased from 61.0% to 64.6% and 8.1% to 14.9%,
respectively, while for the inorganic Se, SeCys and SeMet, it
decreased from 4.4% to 2.7%, 7.1% to 3.1% and 4.2% to 1.5%,
respectively. The distribution of Se in GPx did not change too
much, which is 8.7% and 8.6% before and after Se supplemen-
tation. Our results find that most of the supplemented Se went to
SeAlb, which is in agreement with the findings by Palacios et al.11
On day 360, when the Se supplementation ceased for 6 months,
the Se distribution in SelP and SeAlb is still higher than that on
day 0, while for GPx and other non-retained Se compounds,
inorganic Se, SeCys and SeMet, it is lower than that on day 0.
This may suggest that SelP and SeAlb may serve as the Se pool in
the body while GPx etc. can serve as the indicator of Se intake in
the body.
Organic Se is more efficient at increasing serum Se concen-
trations but not necessarily increasing Se status such as GPx. The
findings of this study show that the concentration of Se species
will reach the top after Se supplementation, i.e., Se in GPx, SelP
and SeAlb reach the maximum distribution on day 90, day 120
and day 90, respectively, but the distribution did not change too
much in the supplementation phase. It can therefore be
concluded that long-term Se supplementation is suitable to
increase and thus improve the body Se pools.
Generally, Se can antagonize the toxicity of Hg in mammals,
which is presumably attributed to the formation of biologically
inert Se–Hg compounds.25 An attempt to search for the possible
inert Se–Hg compounds in the serum samples is still under way in
our lab.
Conclusions
Analysis of Se species (including Se4+ + Se6+, SeCys, SeMet, GPx,
SelP, and SeAlb) in human serum samples is proposed by HPLC-
ICP-qMS through ion-pair reversed phase chromatography and
affinity chromatography with on-line isotope dilution.
The present methodology was applied to study the dynamic
distribution of Se in serum samples in long-term Hg exposed
people before and after Se supplementation. Se in SelP, SeAlb
and GPx accounts for over 77% of total Se while Se in inorganic
Se, SeCys and SeMet accounts for about 15% of total Se before
Se supplementation. After Se supplementation, the distribution
of Se in SelP and SeAlb increased, while decreasing for the
inorganic Se, SeCys and SeMet. The distribution of Se in GPx
did not change too much before and after Se supplementation.
Our results indicate that most of the supplemented Se are bound
to SeAlb. Long-term Se supplementation is suitable to increase
and thus improve the body Se pools even in Hg-exposed people.
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